Efficacy and Safety of OnabotulinumtoxinA in Patients With Neurogenic Detrusor Overactivity Caused by Spinal Cord Injury: A Systematic Review and Meta-analysis

PURPOSE: OnabotulinumtoxinA (BoNT-A) is a promising therapy for treating neurogenic detrusor overactivity (NDO) in individuals with spinal cord injury (SCI). This systematic review and meta-analysis aimed to carry out an in-depth review and to make an objective estimation of the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guang-Ping, Wang, Xiao-Yan, Zhang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312972/
https://www.ncbi.nlm.nih.gov/pubmed/30599499
http://dx.doi.org/10.5213/inj.1836118.059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312972/
https://www.ncbi.nlm.nih.gov/pubmed/30599499
http://dx.doi.org/10.5213/inj.1836118.059

Ejemplares similares